Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris
- 1 April 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (8) , 756-762
- https://doi.org/10.1016/0002-9149(87)91087-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Isosorbide dinitrate and glyceryl trinitrate: Demonstration of cross tolerance in the capacitance vesselsThe American Journal of Cardiology, 1985
- Failure of transdermal nitroglycerin to improve chronic stable angina: A randomized, placebo-controlled, double-blind, double crossover trialAmerican Heart Journal, 1984
- Isosorbide 5-mononitrate kineticsClinical Pharmacology & Therapeutics, 1984
- Treatment of coronary heart disease with isosorbide mononitrate (‘Elantan’ 20): a multi-centre study in hospital and general practiceCurrent Medical Research and Opinion, 1984
- Oral Isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose-response relation during acute and sustained therapyThe American Journal of Cardiology, 1982
- First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal manEuropean Journal of Clinical Pharmacology, 1981
- Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.Circulation, 1980
- Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.Circulation, 1980
- Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate.Circulation, 1977
- Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery diseaseThe American Journal of Medicine, 1977